NUMI

Numinus Wellness (NUMI)

Numinus Wellness Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSXV:NUMI
DateTimeSourceHeadlineSymbolCompany
01/20/20223:01PMPR Newswire (Canada)Numinus Wellness Inc. Reports Q1 2022 Results TSXV:NUMINuminus Wellness Inc
01/19/20227:00AMPR Newswire (Canada)Numinus Announces Key Milestones in MAPS-Sponsored MDMA-Assisted Therapy for PTSD Clinical Trial TSXV:NUMINuminus Wellness Inc
01/14/20227:00AMPR Newswire (Canada)Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary Psilocybin Product TSXV:NUMINuminus Wellness Inc
01/13/20226:32PMPR Newswire (Canada)Numinus Announces Cancellation and Rescheduling of Annual General Meeting of Shareholders TSXV:NUMINuminus Wellness Inc
01/05/20227:00AMPR Newswire (Canada)Numinus to Host Q1 2022 Results Conference Call on January 13, 2022 TSXV:NUMINuminus Wellness Inc
12/22/20214:00PMPR Newswire (Canada)Numinus Wellness Commends Health Canada on Special Access Programme Amendments to Restore Potential Access to Psychedelic Medicines TSXV:NUMINuminus Wellness Inc
12/14/20215:00PMPR Newswire (Canada)Numinus Wellness Inc. to Commence Trading on the TSX on December 16, 2021 TSXV:NUMINuminus Wellness Inc
12/09/20214:02PMPR Newswire (Canada)Numinus Wellness Inc. Reports Q4 and Year End 2021 Results TSXV:NUMINuminus Wellness Inc
11/30/20217:30AMPR Newswire (Canada)Numinus to Participate in the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th TSXV:NUMINuminus Wellness Inc
11/29/20214:30AMPR Newswire (Canada)Numinus Develops Proprietary Psychedelic Tests with New Toxicity and Potency Scans TSXV:NUMINuminus Wellness Inc
11/26/20217:30AMPR Newswire (Canada)Numinus Receives Conditional Approval to Graduate to the Toronto Stock Exchange TSXV:NUMINuminus Wellness Inc
11/25/20215:00PMPR Newswire (Canada)Numinus Announces Departure of Stacey Wallin TSXV:NUMINuminus Wellness Inc
11/22/20217:30AMPR Newswire (Canada)Numinus to Host Q4 and 2021 Annual Results Conference Call on December 9, 2021 TSXV:NUMINuminus Wellness Inc
11/19/20217:30AMPR Newswire (Canada)Numinus to Begin Trading on the OTC Under Symbol NUMIF TSXV:NUMINuminus Wellness Inc
11/10/20214:00AMPR Newswire (Canada)Numinus to Host Extension of MAPS-Sponsored MDMA-Assisted Therapy for PTSD Trials TSXV:NUMINuminus Wellness Inc
10/26/20218:00AMPR Newswire (Canada)Numinus to Participate in Microdose Hosted Events: Psychedelic Capital and Wonderland: Miami TSXV:NUMINuminus Wellness Inc
10/20/20218:00AMPR Newswire (Canada)Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product TSXV:NUMINuminus Wellness Inc
10/18/20217:35AMPR Newswire (Canada)KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing TSXV:NUMINuminus Wellness Inc
10/11/20218:25AMPR Newswire (Canada)KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th TSXV:NUMINuminus Wellness Inc
10/08/20218:00AMPR Newswire (Canada)Numinus Upgrades Psychedelics Lab to Increase Research Service Capabilities TSXV:NUMINuminus Wellness Inc
09/23/20218:00AMPR Newswire (Canada)Numinus Completes Acquisition of Neurology Centre of Toronto TSXV:NUMINuminus Wellness Inc
09/02/20218:00AMPR Newswire (Canada)Numinus to Participate in Upcoming Investor Conferences in September 2021 TSXV:NUMINuminus Wellness Inc
07/29/20215:00PMPR Newswire (Canada)Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology TSXV:NUMINuminus Wellness Inc
07/12/20217:00AMPR Newswire (Canada)Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD TSXV:NUMINuminus Wellness Inc
07/06/20217:00AMPR Newswire (Canada)Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create Centre for Psychedelic Neurology TSXV:NUMINuminus Wellness Inc
06/24/20216:45PMPR Newswire (Canada)Numinus Announces Grant of Stock Options TSXV:NUMINuminus Wellness Inc
06/24/20217:00AMPR Newswire (Canada)Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production Process for Psilocybe and Other Psychoac... TSXV:NUMINuminus Wellness Inc
06/18/20217:00AMPR Newswire (Canada)Numinus Wellness Graduates to Tier 1 on the TSX Venture Exchange TSXV:NUMINuminus Wellness Inc
05/20/20217:45AMNetworkNewsWireNatural Drug Treatments Offer Promise, Potential as Savvy Drug Developers Recognize True Opportunities TSXV:NUMINuminus Wellness Inc
05/13/20217:00AMPR Newswire (Canada)Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and Innovation TSXV:NUMINuminus Wellness Inc
 Showing the most relevant articles for your search:TSXV:NUMI
Your Recent History
TSX
BCE
BCE Inc
TSX
IVN
Ivanhoe Mi..
FX
CADUSD
Canadian D..
USOTC
XUII
Xumanii In..
FX
EURCAD
Euro vs Ca..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:ca D:20220125 17:49:01